Search

Your search keyword '"Colloredo, Guido"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Colloredo, Guido" Remove constraint Author: "Colloredo, Guido"
49 results on '"Colloredo, Guido"'

Search Results

4. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

5. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

6. Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology

7. Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy

9. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years

10. COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization

12. Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581]

14. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

15. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

17. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

18. Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritis

19. Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data

20. Entecavir treatment for NUC naïve, field practice patients with chronic hepatitis B: excellent viral suppression and safety profile over 5 years of treatment: 366

21. Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting for winter season 2020–2021 during the COVID‐19 pandemic

22. Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium

25. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

26. HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients

30. Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019.

34. Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology

35. Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

37. Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.

38. Pegylated Interferon-α2b plus Ribavirin: An Efficacious and well-Tolerated Treatment Regimen for Patients with Hepatitis C virus Related Histologically Proven Cirrhosis

40. Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype

41. Hepatitis C virus RNA profiles in chronically infected individuals: Do they relate to disease activity?

43. Pegylated Interferon-a2b plus Ribavirin: An Efficacious and well-Tolerated Treatment Regimen for Patients with Hepatitis C virus Related Histologically Proven Cirrhosis

45. Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic

46. Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis

47. Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology

48. Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis.

Catalog

Books, media, physical & digital resources